Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ian Driver
LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody–Induced Tumor Cell Killing by Effector CD8+ T Cells
Journal of Immunology
Allergy
Immunology
Related publications
NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines
Cell
Biochemistry
Genetics
Molecular Biology
Pan-BCL-2 Inhibitor AT-101 Enhances Tumor Cell Killing by EGFR Targeted T Cells
PLoS ONE
Multidisciplinary
Increased Cell Surface Free Thiols Identify Effector CD8+ T Cells Undergoing T Cell Receptor Stimulation
PLoS ONE
Multidisciplinary
Ibrutinib Enhances the Efficacy of ROR1 Bispecific T Cell Engager Mediated Cytotoxicity in Chronic Lymphocytic Leukaemia
British Journal of Haematology
Hematology
PS2 - 172 Preclinical Validation of a Novel CD33/CD3 Bispecific T-Cell Engager (BiTE) Antibody to Target Patient-Derived Glioblastoma Cells
Canadian Journal of Neurological Sciences
Medicine
Neurology
CD28 and 41BB Costimulation Enhances the Effector Function of CD19-specific Engager T Cells
Cancer immunology research
Cancer Research
Immunology
Tumor-Induced CD8+ T-Cell Dysfunction in Lung Cancer Patients
Clinical and Developmental Immunology
Regulatory T Cell Depletion Enhances Tumor Specific CD8 T-Cell Responses, Elicited by Tumor Antigen NY-ESO-1b in Hepatocellular Carcinoma Patients, in Vitro
International Journal of Oncology
Cancer Research
Oncology
Blockade of Surface-Bound TGF-β on Regulatory T Cells Abrogates Suppression of Effector T Cell Function in the Tumor Microenvironment
Science Signaling
Biochemistry
Cell Biology
Molecular Biology
